Author:
Chang Yue-Yue,Wu Hai-Long,Fang Huan,Wang Tong,Ouyang Yang-Zi,Sun Xiao-Dong,Tong Gao-Yan,Ding Yu-Jie,Yu Ru-Qin
Funder
National Natural Science Foundation of China
Reference31 articles.
1. Metabolism‐related pharmacokinetic drug- drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations;Teo;Br. J. Clin. Pharmacol.,2015
2. Effects of food on the pharmacokinetics of ponatinib in healthy subjects;Narasimhan;J. Clin. Pharm. Therapeut.,2013
3. Simultaneous analysis of anticancer agents bortezomib, imatinib, nilotinib, dasatinib, erlotinib, lapatinib, sorafenib, sunitinib and vandetanib in human plasma using LC/MS/MS;Andriamanana;J. Chromatogr. B,2013
4. Fast quantitative analysis of four tyrosine kinase inhibitors in different human plasma samples using three‐way calibration‐assisted liquid chromatography with diode array detection;Xiang;J. Separ. Sci.,2015
5. Simultaneous quantification of lenalidomide, ibrutinib and its active metabolite PCI-45227 in rat plasma by LC-MS/MS: application to a pharmacokinetic study;Veeraraghavan;J. Pharmaceut. Biomed. Anal.,2015
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献